Schools Of Public Health Adapting To Societal Needs

The institutions strive to overcome a poor image while looking ahead to a new role in a managed-care environment Sidebar : ACCREDITED SCHOOLS OF PUBLIC HEALTH Once the poor cousins of medical schools, public health schools are coming into their own as universities create new programs or expand existing ones. The advent of managed care, which emphasizes cost-effectiveness, has focused the attention of many institutions on prevention, the traditional raison d'^Ðtre of public health. CON

Written bySteven Benowitz
| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share


The institutions strive to overcome a poor image while looking ahead to a new role in a managed-care environment

Sidebar : ACCREDITED SCHOOLS OF PUBLIC HEALTH

Once the poor cousins of medical schools, public health schools are coming into their own as universities create new programs or expand existing ones. The advent of managed care, which emphasizes cost-effectiveness, has focused the attention of many institutions on prevention, the traditional raison d'^Ðtre of public health.


CONSTANTLY CHANGING: While missions stay the same, public health programs continually evolve, says Columbia's Allan Rosenfield.
Despite the increased interest, image problems persist. Some public health research is dismissed as "soft" and less rigorous than medical research. And funding for prevention research-with the exception of well-publicized efforts against AIDS and infectious diseases-remains difficult to come by.

Many academics and researchers assert that schools of public health are at a crucial stage in their 80-year existence. (The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies